Tohru Izumi

Author PubWeight™ 115.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –. Circ J 2012 3.70
2 Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke 2005 2.56
3 Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma. Blood 2010 2.00
4 Evaluation of the impact of atrial fibrillation on rehospitalization events in heart failure patients in recent years. J Cardiol 2012 2.00
5 A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan. Circ J 2010 1.79
6 Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol 2004 1.57
7 Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. Circ J 2012 1.53
8 Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure. J Am Coll Cardiol 2008 1.52
9 Hemodialysis is an independent predictor of coronary in-stent restenosis after paclitaxel eluting stent implantation. Intern Med 2010 1.46
10 Intensively lowering both low-density lipoprotein cholesterol and blood pressure does not reduce cardiovascular risk in Japanese coronary artery disease patients. Circ J 2011 1.45
11 Two cases of Brugada syndrome associated with spontaneous clinical episodes of coronary vasospasm. Intern Med 2006 1.45
12 Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model. Europace 2012 1.45
13 Effect of hypothermia therapy after outpatient cardiac arrest due to ventricular fibrillation. Circ J 2009 1.41
14 Phosphoglucomutase activity as a novel biomarker in patients with acute myocardial infarction. Circ J 2012 1.40
15 Cardiomyocyte-derived mitochondrial superoxide causes myocardial electrical remodeling by downregulating potassium channels and related molecules. Circ J 2014 1.39
16 Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study). Cardiovasc Drugs Ther 2011 1.37
17 National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J 2002 1.36
18 Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke 2002 1.35
19 Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J 2008 1.27
20 Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation 2009 1.16
21 Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease. Cardiovasc Diabetol 2010 1.07
22 Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J Card Fail 2002 1.07
23 Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia. Lipids Health Dis 2009 0.97
24 Primary cardiac osteosarcoma in a young man with severe congestive heart failure. Intern Med 2007 0.96
25 Phase III clinical pharmacology study of tolvaptan. Cardiovasc Drugs Ther 2011 0.96
26 MRI is useful for diagnosis of H1N1 fulminant myocarditis. Circ J 2010 0.94
27 Clinical significance of corticosteroid therapy for eosinophilic myocarditis. Int Heart J 2011 0.94
28 The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia. J Atheroscler Thromb 2006 0.93
29 Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines. Invest New Drugs 2007 0.93
30 Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy. Heart Vessels 2013 0.93
31 Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit Care Med 2003 0.92
32 Retropharyngeal abscess due to methicillin-resistant Staphylococcus aureus in a case of acute myeloid leukemia. Intern Med 2005 0.92
33 Tumor necrosis factor-alpha downregulates the voltage gated outward K+ current in cultured neonatal rat cardiomyocytes: a possible cause of electrical remodeling in diseased hearts. Circ J 2006 0.92
34 Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. Circ J 2009 0.91
35 Vasospasms of the radial artery after the transradial approach for coronary angiography and angioplasty. Jpn Heart J 2004 0.91
36 Resveratrol ameliorates experimental autoimmune myocarditis. Circ J 2007 0.90
37 Angiotensin II receptor antagonist attenuates expression of aging markers in diabetic mouse heart. Circ J 2006 0.89
38 C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome. Heart Vessels 2003 0.89
39 Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Cardiovasc Drugs Ther 2011 0.89
40 The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases. J Biol Chem 2013 0.89
41 Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy. Heart Vessels 2013 0.88
42 Therapeutic strategy using extracorporeal life support, including appropriate indication, management, limitation and timing of switch to ventricular assist device in patients with acute myocardial infarction. J Artif Organs 2013 0.88
43 Is B-type natriuretic peptide-guided heart failure management cost-effective? Int J Cardiol 2004 0.87
44 Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Jpn Heart J 2003 0.87
45 Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study. Heart Vessels 2013 0.85
46 Inhomogenic effect of bepridil on atrial electrical remodeling in a canine rapid atrial stimulation model. Circ J 2008 0.85
47 Successful treatment of primary cardiac lymphoma with monoclonal CD20 antibody (rituximab). Circ J 2004 0.85
48 Interaction of BMP10 with Tcap may modulate the course of hypertensive cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2007 0.85
49 Prognostic value of gated myocardial perfusion imaging for asymptomatic patients with type 2 diabetes: the J-ACCESS 2 investigation. Diabetes Care 2010 0.85
50 Progression of ventricular remodeling and arrhythmia in the primary hyperoxidative state of glutathione-depleted rats. Circ J 2011 0.84
51 Arrhythmogenic difference between the left and right atria during rapid atrial activation in a canine model of atrial fibrillation. Circ J 2007 0.84
52 Effects of phase II cardiac rehabilitation on job stress and health-related quality of life after return to work in middle-aged patients with acute myocardial infarction. Int Heart J 2009 0.84
53 Effects of the endothelin receptor antagonist bosentan on hemodynamics, symptoms and functional capacity in Japanese patients with severe pulmonary hypertension. Circ J 2005 0.83
54 Verapamil suppresses the inhomogeneity of electrical remodeling in a canine long-term rapid atrial stimulation model. Pacing Clin Electrophysiol 2003 0.83
55 Dietary soy isoflavone-aglycone lowers food intake in female rats with and without ovariectomy. Obesity (Silver Spring) 2008 0.83
56 Increased serum bilirubin levels coincident with heart failure decompensation indicate the need for intravenous inotropic agents. Int Heart J 2007 0.83
57 Cyclic GMP production by ANP, BNP, and NO during worsening and improvement of chronic heart failure. Jpn Heart J 2003 0.83
58 Rapamycin ameliorates experimental autoimmune myocarditis. Int Heart J 2005 0.83
59 Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats. Br J Pharmacol 2003 0.83
60 Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma. J Clin Invest 2015 0.82
61 Role of electrophysiologic study (EPS)-guided preventive therapy for the management of ventricular tachyarrhythmias in patients with heart failure. Circ J 2008 0.81
62 Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation for the secondary prevention of stroke: a subgroup analysis of J-ROCKET AF. J Stroke Cerebrovasc Dis 2013 0.81
63 CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21). Leuk Res 2013 0.81
64 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis. Eur J Nucl Med Mol Imaging 2002 0.81
65 Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure. Cardiovasc Res 2004 0.81
66 Validation of eight genetic risk factors in East Asian populations replicated the association of BRAP with coronary artery disease. J Hum Genet 2009 0.81
67 Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study. Int J Cardiol 2012 0.81
68 [Acute promyelocytic leukemia accompanied by retinoic acid syndrome with complications of acute myocardial infarction and cerebral infarction during treatment with all-trans retinoic acid]. Rinsho Ketsueki 2002 0.81
69 Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid metabolism and renal function in patients with hypertension and type II diabetes mellitus. Cardiovasc Ther 2011 0.81
70 Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging. Eur J Nucl Med Mol Imaging 2009 0.81
71 Immunomodulatory effect of pentoxifylline in suppressing experimental autoimmune myocarditis. Circ J 2002 0.81
72 Prognostic significance of right ventricular dimension on acute decompensation in chronic left-sided heart failure. Int Heart J 2011 0.81
73 Beyond cholesterol lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndrome. Curr Vasc Pharmacol 2008 0.81
74 Usefulness of a simple prognostication score in prediction of the prognoses of patients with out-of-hospital cardiac arrests. Int Heart J 2013 0.81
75 Extremely prolonged elimination of cibenzoline at toxic plasma concentrations in patients with renal impairments. Ther Drug Monit 2002 0.80
76 Walking speed in patients with first acute myocardial infarction who participated in a supervised cardiac rehabilitation program after coronary intervention. Int Heart J 2012 0.80
77 Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure. Intern Med 2006 0.80
78 A national survey on myocarditis associated with influenza H1N1pdm2009 in the pandemic and postpandemic season in Japan. J Infect Chemother 2012 0.80
79 Adaptation to low-intensity exercise on a cycle ergometer by patients with acute myocardial infarction undergoing phase I cardiac rehabilitation. Circ J 2004 0.80
80 The effects of depression on the course of functional limitations in patients with chronic heart failure. J Card Fail 2011 0.80
81 Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome. Nutr Metab (Lond) 2011 0.80
82 Recurrent fulminant viral myocarditis with a short clinical course. Circ J 2003 0.80
83 Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro. Cancer Chemother Pharmacol 2004 0.79
84 Schedule-dependent interactions between pemetrexed and cisplatin in human carcinoma cell lines in vitro. Oncol Res 2006 0.79
85 Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation. Int Heart J 2005 0.79
86 Combined effects of up- and downstream therapies on atrial fibrillation in a canine rapid stimulation model. Int J Cardiol 2010 0.79
87 Atrial natriuretic peptide (ANP) suppresses acute atrial electrical remodeling in the canine rapid atrial stimulation model. Int J Cardiol 2007 0.79
88 Homopiperazine derivatives as a novel class of proteasome inhibitors with a unique mode of proteasome binding. PLoS One 2013 0.79
89 Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent. Catheter Cardiovasc Interv 2013 0.78
90 Predictive impact of the inducibility of ventricular fibrillation in patients with Brugada-type ECG. Int Heart J 2006 0.78
91 The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro. Anticancer Res 2009 0.78
92 Surveillance study for creating the national clinical database relating to ECG-gated myocardial perfusion SPECT of asymptomatic ischemic heart disease in patients with type-2 diabetes mellitus: J-ACCESS 2 study design. Ann Nucl Med 2008 0.78
93 Rivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age. Circ J 2014 0.78
94 Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients. Hypertens Res 2009 0.78
95 Long-term trial of bosentan monotherapy for pulmonary arterial hypertension in Japanese patients. Curr Med Res Opin 2007 0.78
96 Prediction of clinical recurrence of atrioventricular-nodal reentrant tachycardia (AVNRT) after successful slow pathway ablation. Circ J 2004 0.78
97 Event rates of acute myocardial infarction and coronary deaths in Niigata and Nagaoka cities in Japan. Circ J 2003 0.78
98 Initial experience of mobile cloud ECG system contributing to the shortening of door to balloon time in an acute myocardial infarction patient. Int Heart J 2013 0.78
99 Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J 2005 0.78
100 Clinical impact of adherence to guidelines on the outcome of chronic heart failure in Japan. Int Heart J 2008 0.78
101 Long-term follow-up of changes in fibrillation waves in patients with persistent atrial fibrillation: spectral analysis of surface ECG. Circ J 2006 0.78
102 Vanadate improves cardiac function and myocardial energy metabolism in diabetic rat hearts. Jpn Heart J 2003 0.78
103 Efficacy and safety of tolvaptan in heart failure patients with sustained volume overload despite the use of conventional diuretics: a phase III open-label study. Cardiovasc Drugs Ther 2011 0.78
104 Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: a retrospective analysis of JALSG-APL97. Cancer Sci 2013 0.78
105 Predicting the efficacy of antiarrhythmic agents for interrupting persistent atrial fibrillation according to spectral analysis of the fibrillation waves on the surface ECG. Circ J 2009 0.77
106 Patient selection and therapeutic strategy for emergency percutaneous cardiopulmonary system in cardiopulmonary arrest patients. Circ J 2009 0.77
107 Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility. Leuk Lymphoma 2003 0.77
108 Mexiletine protects myocardium during acute ischemia by opening sarcolemmal K-ATP channel: studies in closed-chest acute ischemia model in rabbits. J Cardiovasc Pharmacol 2004 0.77
109 Phospholipid storage in the myocardium of a unique Japanese case of idiopathic cardiomyopathy. Clin Chim Acta 2006 0.77
110 [ACC/AHA 2005 guideline]. Nihon Rinsho 2007 0.77
111 Ezetimibe and reactive oxygen species. Curr Vasc Pharmacol 2011 0.77
112 Bepridil block of recombinant human cardiac IKs current shows a time-dependent unblock. J Cardiovasc Pharmacol 2004 0.77
113 Bepridil inhibits sub-acute phase of atrial electrical remodeling in canine rapid atrial stimulation model. Circ J 2006 0.77
114 Comparison of nitrite compounds and carperitide for initial treatment of acute decompensated heart failure. Int Heart J 2011 0.77
115 Rituximab-induced interstitial pneumonia due to CD8-positive T cell infiltration. Acta Haematol 2012 0.76
116 Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis. Circulation 2006 0.76
117 Electrical remodeling of the ventricular myocardium in myocarditis: studies of rat experimental autoimmune myocarditis. Circ J 2002 0.76
118 Lowering effect of an isoflavone-rich fermented soybean extract on the serum cholesterol concentrations in female rats, with or without ovariectomy, but not in male rats. Biosci Biotechnol Biochem 2006 0.76
119 Primary peripheral T-cell lymphoma, not otherwise specified of the thyroid with autoimmune thyroiditis. Br J Haematol 2013 0.76
120 N-acetylcysteine suppresses the progression of ventricular remodeling in acute myocarditis: studies in an experimental autoimmune myocarditis (EAM) model. Circ J 2010 0.76
121 Conduction system abnormalities in rat embryos induced by maternal hyperthermia. Anat Rec 2002 0.76
122 Lack of an inducible effect of dietary soy isoflavones on the mRNA abundance of hepatic cytochrome P-450 isozymes in rats. Biosci Biotechnol Biochem 2004 0.76
123 Effect of persistent activation of phosphoinositide 3-kinase on heart. Life Sci 2012 0.75
124 Neutral endopeptidase inhibitor suppresses the early phase of atrial electrical remodeling in a canine rapid atrial pacing model. Indian Pacing Electrophysiol J 2008 0.75
125 Author's reply: To PMID 22429679. J Cardiol 2013 0.75
126 Cardioprotective effects of sarcolemmal and mitochondrial K-ATP channel openers in an experimental model of autoimmune myocarditis. Role of the reduction in calcium overload during acute heart failure. Int Heart J 2012 0.75
127 Prolonged recovery time in the left precordial leads reflects increased left ventricular mass in the hypertensive patients. J Electrocardiol 2005 0.75
128 [No 123I-BMIPP accumulation in the myocardium and type I CD36 deficiency in a patient with acute subendocardial infarction: a case report]. Kaku Igaku 2002 0.75
129 [MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma]. Gan To Kagaku Ryoho 2007 0.75
130 Functional limitations predict the risk of rehospitalization among patients with chronic heart failure. Circ J 2012 0.75
131 Monitoring the progression of the atrial electrical remodeling in patients with paroxysmal atrial fibrillation. Circ J 2003 0.75
132 [ACE inhibitor]. Nihon Rinsho 2006 0.75
133 Clinical characteristics of heart disease patients with a good prognosis in spite of markedly increased plasma levels of type-B natriuretic peptide (BNP): anomalous behavior of plasma BNP in hypertrophic cardiomyopathy. Circ J 2005 0.75
134 Repetitive evaluation of fibrillation cycle length predicts the efficacy of bepridil for interruption of long-lasting persistent atrial fibrillation. Int Heart J 2011 0.75
135 Prosthetic mitral valve endocarditis with left atrial dissection. Circ J 2013 0.75
136 [Bortezomib-based triple combinations (VCD, PAD) for untreated patients with multiple myeloma]. Nihon Rinsho 2015 0.75
137 End-tidal carbon dioxide concentration can estimate the appropriate timing for weaning off from extracorporeal membrane oxygenation for refractory circulatory failure. Int Heart J 2010 0.75
138 Identification of the breakpoints at 1p36.2 and 3p21.3 in an AML(M3) patient who had t(1;3)(p36.2;p21.3) at the third relapse. Genes Chromosomes Cancer 2002 0.75
139 Cost-effectiveness analysis of carvedilol for the treatment of chronic heart failure in Japan. Circ J 2004 0.75
140 A young girl with vasospastic angina associated with mutation in endothelial nitric oxide synthase gene--a case report. Angiology 2003 0.75
141 Rationale and design of a study to examine lower targets for low-density lipoprotein-cholesterol and blood pressure in coronary artery disease patients. Circ J 2008 0.75
142 Soluble Fms-like tyrosine kinase 1 is a novel predictor of brain natriuretic peptide elevation. Int Heart J 2013 0.75
143 Measurement of body surface energy leakage of defibrillation shock by an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2002 0.75
144 Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia. Circ J 2006 0.75
145 Risks and benefits of combined use of bucolome and warfarin in anticoagulation therapy. Int Heart J 2010 0.75
146 [Cardiotoxicity of non-cardiac drugs]. Nihon Rinsho 2007 0.75
147 Decreased expression of Na+/H+ exchanger isoform 1 (NHE1) in non-infarcted myocardium after acute myocardial infarction. Jpn Heart J 2002 0.75
148 Effects of electrical muscle stimulation in a left ventricular assist device patient. Int J Cardiol 2012 0.75
149 Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring. Europace 2007 0.75
150 Cardioprotective effect of mexiletine in acute myocardial ischemia tudies in the rabbit closed chest ischemia mode. Circ J 2002 0.75
151 Evaluation of exercise-induced T wave changes in patients with idiopathic dilated cardiomyopathy before and after beta-blocker therapy. J Cardiovasc Electrophysiol 2006 0.75
152 [Drug-induced myocarditis]. Nihon Rinsho 2007 0.75
153 Long-term results of dose-intensive chemotherapy with G-CSF support (TCC-NHL-91) for advanced intermediate-grade non-Hodgkin's lymphoma: a review of 59 consecutive cases treated at a single institute. Oncol Res 2008 0.75
154 t(1;3)(p36;p21) is a recurring therapy-related translocation. Genes Chromosomes Cancer 2002 0.75
155 Bepridil prevents paroxysmal atrial fibrillation by a class III antiarrhythmic drug effect. Pacing Clin Electrophysiol 2003 0.75
156 Prediction of inappropriate implantable cardioverter-defibrillator therapies through parameters obtained in a simple exercise stress test. Int Heart J 2012 0.75
157 Clinical usefulness of electrophysiologic study (EPS)-guided risk stratification for life-threatening arrhythmia in patients with heart failure. Int Heart J 2007 0.75
158 Evaluation of the effect of bepridil on paroxysmal atrial fibrillation: relationship between efficacy and the f-f interval in surface ECG recordings. Circ J 2003 0.75
159 A long course of leukocytopenia and splenomegaly with extramedullary hematopoiesis in the absence of clinically manifested rheumatoid arthritis. J Clin Exp Hematop 2010 0.75
160 [Drug-induced cardiotoxicity]. Nihon Rinsho 2012 0.75
161 [Novel targeted therapy in multiple myeloma]. Nihon Rinsho 2014 0.75
162 Importance of morphological changes in T-U waves during bepridil therapy as a predictor of ventricular arrhythmic event. Circ J 2010 0.75
163 [Calcium sensitizer: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects]. Nihon Rinsho 2007 0.75
164 [Successful treatment of hairy cell leukemia prolymphocytic variant with 2'-deoxycoformycin]. Rinsho Ketsueki 2002 0.75